GGrantIndex
Sort

34,240 grants matching atherosclerosis

Treating Sleep Apnea in Type 2 Diabetes Mellitus: A Randomized Clinical Trial

$775,833
Naresh Punjabi · Johns Hopkins University · R01 · FY2016 · HL

Elucidating the Role of Adipokines in Mediating and Predicting HF Associated with Obesity

$775,761
Chiadi E Ndumele · Johns Hopkins University · R01 · FY2023 · HL

Arsenic Exposure, Cardiovascular Disease and Diabetes in Native Americans

$775,726
Ana Navas-Acien · Johns Hopkins University · R01 · FY2010 · HL

Endothelial protocadherins in vascular development and disease

$775,720
Martin A. Schwartz · Yale University · R01 · FY2025 · HL

Endothelial Dysfunction, Biomarkers and Lung Function

$775,687
R Graham Barr · Columbia University Health Sciences · R01 · FY2006 · HL

Air Pollution and Preclinical Atherosclerosis in Elementary-School Children

$775,640
Edward Avol · University Of Southern California · R01 · FY2009 · ES

REasons for Geographic And Racial Differences in Stroke-Myocardial Infarction-2

$775,564
Monika M Safford · University Of Alabama At Birmingham · R01 · FY2012 · HL

Dissecting Causal Role of Insomnia in Cardiovascular Disease

$775,399
Richa Saxena · Massachusetts General Hospital · R01 · FY2020 · HL

Clonal hematopoiesis, inflammasomes and atherosclerosis

$775,384
Alan Richard Tall · Columbia University Health Sciences · R01 · FY2025 · HL

Investigating Mechanisms for Lipid Transport in Health and Disease

$775,320
Stephen G Young · University Of California Los Angeles · R35 · FY2020 · HL

Investigating Mechanisms for Lipid Transport in Health and Disease

$775,320
Stephen G Young · University Of California Los Angeles · R35 · FY2019 · HL

Vascular-targeted Atheroprotective Gene therapies to Prevent Vein Graft Failure

$775,234
Christiane Ferran · Beth Israel Deaconess Medical Center · R01 · FY2024 · HL

Epigenetics of energy homeostasis, bioenergetics and obesity

$775,157
Melanie Carless · University Of Texas San Antonio · R01 · FY2020 · DK

Cellular Adhesion Molecules: Genes, Phenotypes, and Coronary Atherosclerosis

$775,140
Myron D Gross · University Of Minnesota · R01 · FY2009 · HL

Gene Transcripts and Proteomics in Families with Platelet Hyperaggregation

$775,039
Lewis C Becker · Johns Hopkins University · R01 · FY2016 · HL

Rheumatoid Arthritis and the Risk of Cardiovascular Disease: Biomarkers Risk Prediction and Underlying Mechanisms

$774,845
Daniel Hal Solomon · Brigham And Women'S Hospital · R01 · FY2024 · HL

Characterization of cardiovascular diseases (CVD) in people with long duration Type 1 diabetes

$774,662
George L King · Joslin Diabetes Center · R01 · FY2024 · HL

Long Life Family Study: University of Pittsburgh Field Center

$774,570
Joseph M Zmuda · University Of Pittsburgh At Pittsburgh · U01 · FY2017 · AG

LOX-1 as a protective countermeasure in response to lung infection

$774,500
Lee Quinton · Univ Of Massachusetts Med Sch Worcester · R01 · FY2023 · HL

Inhibitors of Tyrosine Kinase-Dependent Signalling as Anti-Cancer Agents

$774,242
Terrence Burke · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA

DISCOVERY - Statistics and Analysis Core

$774,212
Rebecca F Gottesman · Massachusetts General Hospital · U19 · FY2019 · NS

Comprehensive Magnetic Resonance in PAD

$774,074
Christopher M Kramer · University Of Virginia · R01 · FY2007 · HL

Contribution of novel lysoplasmalogenases enzymes in regulating macrophage immunometabolic responses in cardiovascular disease

$773,997
Carlos Fernandez Hernando · Yale University · R01 · FY2024 · HL

Sexual dimorphism in susceptibility to emphysematous tissue injury

$773,943
Yun Michael Shim · University Of Virginia · R01 · FY2023 · HL

IDOL and dyslipidemia in cardiovascular diseases

$773,938
Yuqing E Chen · University Of Michigan At Ann Arbor · R01 · FY2019 · HL